Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-04-30

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Reduction of the spinal cord injuries during scoliosis surgery is a major goal of the anesthesia and surgical team. Despite improvement in scoliosis surgery over the years, the development of neurological deficits remains the most feared complication of spine surgery. During scoliosis surgery it is very important to monitor the spinal cord to detect spinal cord injury with surgical manipulation. Continuous or intermittent intraoperative electrophysiological monitoring (neuron-monitoring) is used routinely during these procedures to provide the surgeon with information concerning the integrity of neurological structures at risk. All neuron-monitoring modalities are affected by the anesthetic regimen used. Of the various intravenous anesthetic drugs, the combination of propofol, remifentanil and dexmedetomidine appear to impact neuron-monitoring the least. The current anesthetic practice is to use the three drugs in combination at doses that do not depress the signals but there is no data relating targeted dexmedetomidine and propofol blood levels to neuron-monitoring signals. The lack of data results in wide variability in dosing with consequent variability in patient response.

Hypothesis: Clinically relevant blood levels of dexmedetomidine will affect the amplitude of transcranial motor-evoked potentials (TcMEP) either independently or by interaction with propofol in a dose dependent manner.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

NCT06067893

Spinal Fusion Adolescent Idiopathic Scoliosis

ENROLLING_BY_INVITATION PHASE4

Dexmedetomidine on Intraoperative Somatosensory and Motor Evoked Potential Monitoring During Neurosurgery in Pediatric Patients

NCT01512147

Tethered Spinal Cord Brain Tumor Cranio Cervical Compression

COMPLETED NA

Effects of Anesthetic Infusion on the Amplitude of Motor Evoked Potential in Pediatrics Undergoing Tethered Spinal Cord Surgeries

NCT05591001

Tethered Cord

COMPLETED PHASE1

Spinal or Intravenous Dexmedetomidine in Ambulatory Surgery

NCT02282319

Surgery Ambulatory

COMPLETED PHASE4

Comparison of Different Doses of Dexmedetomidine Effect in the Duration of Spinal Anesthesia

NCT03143010

Spinal Anesthesia Duration

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Scoliosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Blinding Strategy

NONE

Intervention Type DRUG

Dexmedetomidine loading dose 0.6 MCG/KG,Propofol infusion 200 MCG/KG/M

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects must be 10 to 25 years of age
* Diagnosis of idiopathic scoliosis is established
* Subject's legal authorized representative has given written, informed consent to participate in the study and, where appropriate, the subject has given assent to participate
* American society of Anesthesiology physical status one/two
* Patients scheduled for posterior spinal fusion only

Exclusion Criteria

* • Patients with neuromuscular scoliosis and patients with motor or sensory deficit in the lower extremities

* Patients with allergy to, or contraindication for the drugs or techniques used in the study
* Morbid obesity (Body mass index higher than 40)
* History of malignant hyperthermia
* Patient with severe cardiopulmonary disease (pulmonary hypertension, cardiomyopathy, mechanical ventilation)

Minimum Eligible Age

10 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No